Nevertheless, it is important to highlight that elevated plasma concentrations of BCAAs in individuals with overweight/obesity and patients with T2DM correlate with insulin resistance30–32 and pharmaceutical stimulation of BCAA oxidation via sodium phenylbutyrate treatment significantly increases insulin sensitivity T2DM patients33. Here, INS is linked to type 2 diabetes mellitus.